Do you live with nasal polyps?
Do you care for someone who does?
The Canadian Agency for Drugs and Technologies in Health (CADTH) is interested in understanding the real impact that diseases and their treatments have on the daily lives of patients and caregivers. This helps inform their decisions of drug approvals and funding.
Asthma Canada helps patients have a say in the consideration of medications related to asthma and comorbidities including nasal polyps.
The short survey has been created to determine how nasal polyps affects your day-to-day life. This helps decision makers understand the personal implications of a particular illness and its treatments. Information received will be submitted to CADTH to inform their consideration of a new treatment option to Canada.
This is an important way for your voice to be heard by the Government of Canada to help influence key decisions that will affect the asthma community.
In order to add your voice to this process, please complete this survey by Tuesday May 24, 2022. It should take about ten minutes of your time.
Thank you!
New Survey Highlights Challenges Faced by 4.6 Million Canadians Living with Asthma In News & Updates
Data from new national study exposes oral corticosteroids overuse in Canadian patients with severe asthmaIn News & Updates
In the Community: Rudhro Prince Memorial Walk 2024In News & Updates
Asthma Canada Seeks Input from Community to Shape Future Research PrioritiesIn News & Updates
Asthma Canada Urges Parents to be Extra Vigilant with Their Child’s Asthma Management Routine as “September Asthma Peak” ApproachesIn News & Updates